Lobbying

The Academy Advisors's latest lobbying report covers Q2 2026, at $80K. The four quarters Q4 2025–Q3 2026 total $210K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.

The Academy Advisors

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$210K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

The Academy Advisors lobbying by quarter
The Academy Advisors lobbying by quarter
QuarterAmountReports
Q4 2022$100K2
Q1 2023$110K2
Q2 2023$70K2
Q3 2023$70K3
Q4 2023$60K2
Q1 2024$60K2
Q2 2024$60K2
Q3 2024$60K2
Q4 2024$60K2
Q1 2025$90K2
Q2 2025$70K2
Q3 2025$70K2
Q4 2025$60K2
Q1 2026$70K2
Q2 2026$80K2
Q3 2026$00

By issue

  • Health issues$785K · 28 reports
  • Medicare and Medicaid$255K · 13 reports
  • Insurance$10K · 2 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES28 reports
  • SENATE28 reports
  • Centers For Medicare and Medicaid Services (CMS)5 reports

Firms it paid

Firm
In-houseThe Academy Advisors$760K15 quarters
Venable$200K10 quarters
Alpine Group Partners$100K4 quarters
Winning Strategies Washington$30K2 quarters

Former officials lobbying for it

Former position
BRYAN RICKERRegional Director, Sen. CrapoQ2 2026
CHARLA PENNLA, Rep. Pascrell; SA/LC/LA, Rep. BoydQ2 2026
CHELSEY PENROD HICKMANCoS, LD, Rep. Kay Granger; Deputy LD, LA Sen. Larry CraigQ2 2026
ELIZABETH CONNOLLYAssistant Director of Public Health, Office of National Drug Control PolicyQ2 2026
MICHAEL A MEROLADeputy CoS, Sen. TorricelliQ2 2026
COURTNEY JOHNSONResearch Assistant, House Energy & Commerce CommitteeQ3 2023

Lobbying reports

Filed by
07/16for Q2Winning Strategies Washington$30K
07/16for Q2In-house$50K
04/18for Q1Winning Strategies WashingtonUnder $5,000
04/15for Q1Winning Strategies WashingtonUnder $5,000
04/13for Q1In-house$70K
01/09for Q4 2025Venable$20K
01/08for Q4 2025In-house$40K
25/10/20for Q3 2025In-house$50K
25/10/06for Q3 2025Venable$20K
25/07/14for Q2 2025In-house$50K
25/07/10for Q2 2025Venable$20K
25/04/18for Q1 2025In-house$70K
25/04/11for Q1 2025Venable$20K
25/01/21for Q4 2024Venable$20K
25/01/21for Q4 2024In-house$40K
24/10/16for Q3 2024Venable$20K
24/10/10for Q3 2024In-house$40K
24/07/18for Q2 2024Venable$20K
24/07/17for Q2 2024In-house$40K
24/04/22for Q1 2024Venable$20K